U.S. markets closed
  • S&P 500

    3,271.03
    -119.65 (-3.53%)
     
  • Dow 30

    26,519.95
    -943.24 (-3.43%)
     
  • Nasdaq

    11,004.87
    -426.48 (-3.73%)
     
  • Russell 2000

    1,543.28
    -47.21 (-2.97%)
     
  • Crude Oil

    37.59
    +0.20 (+0.53%)
     
  • Gold

    1,878.30
    -0.90 (-0.05%)
     
  • Silver

    23.45
    +0.10 (+0.41%)
     
  • EUR/USD

    1.1748
    -0.0042 (-0.35%)
     
  • 10-Yr Bond

    0.7810
    +0.0030 (+0.39%)
     
  • GBP/USD

    1.2983
    -0.0059 (-0.45%)
     
  • USD/JPY

    104.2900
    -0.2040 (-0.20%)
     
  • BTC-USD

    13,269.70
    +68.81 (+0.52%)
     
  • CMC Crypto 200

    261.22
    -11.47 (-4.20%)
     
  • FTSE 100

    5,582.80
    -146.19 (-2.55%)
     
  • Nikkei 225

    23,418.51
    -67.29 (-0.29%)
     

FDA, EU diverge on AstraZeneca COVID-19 vaccine

The Food and Drug Administration widened its probe into a serious illness linked to halted clinical trials for AstraZeneca's potential COVID-19 vaccine, sources told Reuters, while in Europe the vaccine approval process has been put on the fast track. Conway G. Gittens reports.